Collegium Pharmaceutical, Inc. COLL Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s pre-tax income?
- Collegium Pharmaceutical, Inc. (COLL) reported pre-tax income of $18.74M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s pre-tax income changed year-over-year?
- Collegium Pharmaceutical, Inc.'s pre-tax income increased by 500.3% year-over-year, from $3.12M to $18.74M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s pre-tax income?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s pre-tax income has grown at a 128.9% compound annual growth rate (CAGR), from -$3.37M to $92.62M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.